SCHEMBL5908050

SCHEMBL5908050

CC(C)(C)CNC1(Cl)N=CC(CCl)=CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4143014 0.81
SCHEMBL9169733 0.69
SCHEMBL19686876 0.51 S1PR2 (0.41)
SCHEMBL9086602 0.51 IDH1 (0.42)
SCHEMBL19468970 0.49 CTSD (0.44)
SCHEMBL23943143 0.48 NUDT1 (0.35)
SCHEMBL16487279 0.47 AR (0.38)
SCHEMBL16978959 0.47 IDH1 (0.52)
SCHEMBL9278638 0.46 ALDH1A1 (0.54)
SCHEMBL23366110 0.45 AR (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060074092-A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for the treatment of inflammations and other diseases ALTMANN EVA 2006-04-06 US disclosed